Supported Research
-
-
Today 80% of FA patients survive beyond age 20, carrying a high risk for SCC of the oropharyngeal and anogenital regions connected with high morbidity and mortality. In addition to intrinsic genetic instability, HSCT and a number of other factors contribute to the pathogenesis of...
The Latest
News & Events
![](https://fanconi.org/wp-content/uploads/2024/06/IMG_1499s-scaled-e1718991245321-1024x554.jpg)
My lab’s vision for the next five years is to apply what we have learned to develop molecules that can alter FA protein behavior. These could be used to treat cancer or alter gene editing outcomes.
![](https://fanconi.org/wp-content/uploads/2024/06/Omar7-778x1024.png)
In a world where every day presents new challenges, my 11-year-old son, Omar, from Oman, stands out for his resilience and eagerness to raise awareness about Fanconi anemia. Diagnosed at just five years old, we truly believe his journey is a testament to hope and the strength of the human spirit.
![](https://fanconi.org/wp-content/uploads/2024/04/Copy-of-FCF-Social-Media-Templates-1024x1024.png)
That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).